Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 8 Breast Neoplasms 7 Uterine Cervical Neoplasms 6 Uterine Cervical Dysplasia 5 Persistent Infection 4 Melanoma 4 Glioblastoma 3 Carcinoma, Non-Small-Cell Lung 3 Sarcoma 2 Neuroblastoma 2 Lung Neoplasms 2 Influenza, Human 2 HIV Infections 2 Glioma 2 Condylomata Acuminata 2 Breast Neoplasms, Male 2 Wilms Tumor 1 Waldenstrom Macroglobulinemia 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Spondylitis, Ankylosing 1 Small Cell Lung Carcinoma 1 Rheumatic Diseases 1 Recurrence 1 Psoriasis 1 Prostatic Neoplasms 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Neuroectodermal Tumors, Primitive 1 Neoplasms, Nerve Tissue 1

Interventions

Etoposide 79 Carboplatin 67 Cisplatin 58 durvalumab 30 Irinotecan 29 Radiotherapy 27 atezolizumab 23 Topotecan 21 anlotinib 19 Nivolumab 15 Drug Therapy 15 Radiosurgery 14 Paclitaxel 13 Gemcitabine 13 apatinib 12 toripalimab 10 Platinum 10 Docetaxel 10 tislelizumab 9 Temozolomide 9 PM 01183 9 pembrolizumab 7 olaparib 7 Magnetic Resonance Spectroscopy 7 Ipilimumab 7 Bevacizumab 7 Albumin-Bound Paclitaxel 7 irinotecan sucrosofate 6 Counseling 6 sintilimab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Small Cell Lung Carcinoma × Vaccines × Clear all

NCT04487756 2026-06-02

VENEZO-LUNG

Instituto Oncológico Dr Rosell

Phase 1/2 Completed

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡